EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 10.75p on 07-01-2026 at 08:03:18 |
|---|---|
| Change | 0.00p 0% |
| Buy | 11.00p |
| Sell | 10.50p |
| Last Trade: | Buy 588.00 at 10.80p |
| Day's Volume: | 951 |
| Last Close: | 10.75p |
| Open: | 10.75p |
| ISIN: | GB00BYV81293 |
| Day's Range | 10.75p - 10.75p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £114.79m |
| VWAP: | 10.79905p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 588 | 10.80p | Ordinary |
08:03:17 - 07-Jan-26 |
| Buy* | 363 | 10.7975p | Ordinary |
08:02:57 - 07-Jan-26 |
| Buy* | 11,757 | 10.78p | Ordinary |
16:29:46 - 06-Jan-26 |
| Buy* | 9,230 | 10.78p | Ordinary |
16:20:29 - 06-Jan-26 |
| Sell* | 112 | 10.50p | Ordinary |
16:10:55 - 06-Jan-26 |
| Sell* | 47,409 | 10.555p | Ordinary |
15:25:21 - 06-Jan-26 |
| Buy* | 9,150 | 10.7975p | Ordinary |
15:23:15 - 06-Jan-26 |
| Buy* | 1 | 11.00p | Ordinary |
15:11:50 - 06-Jan-26 |
| Buy* | 4,630 | 10.7975p | Ordinary |
15:01:04 - 06-Jan-26 |
| Sell* | 139,541 | 10.50p | Ordinary |
14:29:43 - 06-Jan-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Jan 2026 11:06 am | RNS | Block listing 6 Monthly Return |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 18th Dec 2025 7:13 am | RNS | Block Listing Application |
| 11th Dec 2025 7:00 am | RNS-R | Shield Wins Gold at Titan Branding Awards |
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |